Rak jajnika
Diagnostyka i diagnoza

Rak jajnika charakteryzuje się wysoką śmiertelnością i niskim 5-letnim wskaźnikiem przeżycia poniżej 50%, głównie z powodu późnej diagnozy – ponad 75% pacjentek jest diagnozowanych w zaawansowanym stadium. Diagnostyka opiera się na szczegółowym wywiadzie, badaniu ginekologicznym oraz badaniach obrazowych, takich jak USG przezpochwowe, tomografia komputerowa (CT), rezonans magnetyczny (MRI) i PET, które służą do oceny lokalizacji i zaawansowania choroby. Marker nowotworowy CA-125, choć powszechnie stosowany, ma ograniczoną czułość i specyficzność, zwłaszcza we wczesnych stadiach, dlatego nie jest rekomendowany jako test przesiewowy w populacji ogólnej. W diagnostyce wspomagającej stosuje się także markery HE4, algorytm ROMA oraz test OVA1, jednak ich zastosowanie wymaga integracji z badaniami obrazowymi i oceną kliniczną. Biopsja, najczęściej wykonywana podczas laparoskopii lub laparotomii, pozostaje złotym standardem potwierdzenia rozpoznania raka jajnika.

Diagnostyka Raka Jajnika

Rak jajnika (rak jajnika) jest jednym z najbardziej śmiertelnych nowotworów ginekologicznych, charakteryzującym się niskim wskaźnikiem przeżycia 5-letniego, wynoszącym poniżej 50%. Trudność w diagnozie tego nowotworu wynika głównie z faktu, że wczesne stadia choroby zazwyczaj nie dają charakterystycznych objawów, a symptomy w późniejszych stadiach są niespecyficzne. Ponad 75% kobiet diagnozowanych jest w zaawansowanym stadium choroby, co znacząco wpływa na rokowanie.123

Wyzwania w diagnostyce raka jajnika

Obecnie nie istnieje skuteczny test przesiewowy dla raka jajnika, który mógłby być stosowany w populacji ogólnej. Badanie cytologiczne (Pap test) nie wykrywa raka jajnika, służy jedynie do wykrywania raka szyjki macicy.12 Amerykańska grupa USPSTF (United States Preventative Services Task Force) nie zaleca rutynowych badań przesiewowych w kierunku raka jajnika, ponieważ potencjalne szkody przewyższają potencjalne korzyści.12

Do głównych wyzwań w diagnostyce raka jajnika należą:

  • Brak skutecznych metod wczesnego wykrywania1
  • Niespecyficzne objawy, które mogą być mylone z innymi schorzeniami1
  • Brak pojedynczego, niezawodnego testu diagnostycznego1
  • Konieczność wykonania biopsji do potwierdzenia diagnozy1

Badanie przedmiotowe i podmiotowe

Proces diagnostyczny raka jajnika zazwyczaj rozpoczyna się od wizyty u lekarza rodzinnego lub ginekologa. Lekarz przeprowadza szczegółowy wywiad medyczny, pytając o objawy, historię zdrowia pacjentki oraz przypadki raka w rodzinie.12

Badanie ginekologiczne

Badanie ginekologiczne jest często pierwszym badaniem wykonywanym przy podejrzeniu raka jajnika. Podczas badania lekarz wprowadza jeden lub dwa palce w rękawiczkach do pochwy, jednocześnie uciskając brzuch, aby sprawdzić macicę, jajniki i inne narządy pod kątem nieprawidłowości, takich jak guzy lub powiększone narządy.12

Badanie to może obejmować również badanie odbytnicze, które pozwala lekarzowi na dokładniejszą ocenę narządów miednicy. Jednak wykrycie raka jajnika wyłącznie na podstawie badania ginekologicznego jest rzadkie, szczególnie we wczesnym stadium choroby.1

Badania obrazowe w diagnostyce raka jajnika

Ultrasonografia

Ultrasonografia (USG) jest zazwyczaj pierwszym badaniem obrazowym wykonywanym przy podejrzeniu raka jajnika. Wyróżniamy dwa rodzaje badania USG w diagnostyce raka jajnika:12

  • USG przezpochwowe (transvaginal ultrasound, TVU) – sonda wprowadzana jest do pochwy, co umożliwia dokładniejszą wizualizację jajników i struktur miednicy. Jest to preferowana metoda ze względu na lepszą jakość obrazowania1
  • USG przezbrzuszne – sonda jest przesuwana po powierzchni brzucha1

Badanie USG pozwala na ocenę zmian w jajnikach, wykrycie torbieli lub guzów oraz ocenę ich charakteru (lite vs. płynowe). Nie może jednak definitywnie stwierdzić, czy wykryta zmiana jest złośliwa czy łagodna.12

Tomografia komputerowa (CT)

Tomografia komputerowa (CT) wykorzystuje promienie rentgenowskie do tworzenia szczegółowych, trójwymiarowych obrazów wnętrza ciała. W diagnostyce raka jajnika CT jest stosowane do:12

  • Oceny miednicy i jamy brzusznej
  • Sprawdzenia, czy nowotwór rozprzestrzenił się na inne narządy lub tkanki
  • Określenia stopnia zaawansowania choroby
  • Prowadzenia igły podczas biopsji obszaru podejrzanego o przerzuty

Rezonans magnetyczny (MRI)

Rezonans magnetyczny (MRI) wykorzystuje pole magnetyczne i fale radiowe do tworzenia szczegółowych obrazów narządów i tkanek. W diagnostyce raka jajnika MRI jest stosowany do:12

  • Dokładnej oceny miednicy i jamy brzusznej
  • Różnicowania między zmianami łagodnymi a złośliwymi
  • Oceny rozprzestrzeniania się nowotworu
  • Prowadzenia igły podczas biopsji

Pozytonowa tomografia emisyjna (PET)

Badanie PET może być stosowane do wykrywania raka jajnika, który nawrócił lub rozprzestrzenił się na inne narządy lub tkanki. PET jest szczególnie przydatny w ocenie aktywności metabolicznej komórek nowotworowych.12

W nowszych podejściach diagnostycznych łączy się badanie PET/CT z oznaczaniem stężenia CA-125 w surowicy, co może poprawić skuteczność wczesnego wykrywania raka jajnika.12

Badania laboratoryjne

Marker CA-125

CA-125 (Cancer Antigen 125) to białko, które często występuje na powierzchni komórek raka jajnika. Test krwi na CA-125 jest najczęściej stosowanym markerem nowotworowym w diagnostyce raka jajnika.12

Podwyższony poziom CA-125 może wskazywać na raka jajnika, ale należy pamiętać, że:12

  • Poziom CA-125 może być podwyższony również w innych stanach nienowotworowych, takich jak endometrioza, stan zapalny miednicy, ciąża czy mięśniaki macicy
  • U około 50% kobiet z wczesnym stadium raka jajnika poziom CA-125 może być prawidłowy
  • Test CA-125 jest najbardziej przydatny u kobiet po menopauzie z masą w miednicy

Z tych powodów test CA-125 nie jest zalecany jako samodzielne badanie przesiewowe w kierunku raka jajnika w populacji ogólnej. Jest on jednak przydatny w monitorowaniu odpowiedzi na leczenie i wykrywaniu nawrotu choroby po zakończeniu leczenia.12

Inne markery nowotworowe

Oprócz CA-125, w diagnostyce raka jajnika mogą być badane również inne markery nowotworowe:123

Należy podkreślić, że nawet gdy te testy są dopuszczone przez FDA, nie są one przeznaczone do stosowania jako samodzielne testy przesiewowe lub diagnostyczne i powinny być stosowane w połączeniu z dodatkowymi badaniami obrazowymi lub oceną kliniczną.1

Badania genetyczne

Badania genetyczne odgrywają ważną rolę w diagnostyce i leczeniu raka jajnika. Mutacje w genach BRCA1 i BRCA2 oraz innych genach zwiększają ryzyko zachorowania na raka jajnika.12

U kobiet z rozpoznanym rakiem jajnika typu nabłonkowego zaleca się ocenę ryzyka genetycznego. Badania genetyczne mogą być oferowane, jeśli pacjentka spełnia określone kryteria kliniczne, osobiste i/lub rodzinne.12

Wyniki badań genetycznych mogą pomóc w:12

  • Projektowaniu bardziej świadomego planu leczenia
  • Wyborze odpowiedniej terapii celowanej
  • Zapobieganiu nawrotom choroby
  • Ochronie członków rodziny przed rakiem jajnika

Raki jajnika z mutacjami w genach BRCA są bardziej podatne na leczenie inhibitorami PARP, co podkreśla znaczenie badań genetycznych w personalizacji terapii.12

Biopsja i procedury chirurgiczne w diagnostyce raka jajnika

Biopsja jest jedynym sposobem na definitywne potwierdzenie diagnozy raka jajnika. Polega ona na pobraniu próbki tkanki z guza w celu zbadania jej pod mikroskopem przez patologa.12

Laparoskopia

Laparoskopia (chirurgia minimalnie inwazyjna) to procedura, podczas której chirurg wprowadza cienką rurę z kamerą (laparoskop) do jamy brzusznej przez małe nacięcie. Pozwala to na ocenę narządów w obrębie miednicy i jamy brzusznej oraz pobranie próbek tkanek do badania (biopsja).12

Laparotomia

Laparotomia to zabieg chirurgiczny, podczas którego wykonuje się większe nacięcie w jamie brzusznej, aby umożliwić chirurgowi bezpośredni dostęp do narządów w miednicy i jamie brzusznej. Jest to częsta procedura stosowana w diagnostyce i leczeniu raka jajnika.12

Podczas laparotomii chirurg:12

  • Bada narządy w miednicy i jamie brzusznej pod kątem oznak nowotworu
  • Może pobrać próbki tkanek lub płynu do badania
  • Jeśli zostanie zdiagnozowany rak jajnika, chirurg zazwyczaj przystępuje do usunięcia jak największej ilości tkanki nowotworowej (cytoredukcja)

Biopsja cienkoigłowa

Biopsja cienkoigłowa polega na wprowadzeniu cienkiej igły przez skórę do guza pod kontrolą obrazowania (USG lub CT). Jest to mniej inwazyjna metoda niż laparoskopia czy laparotomia, ale może nie dostarczyć wystarczającej ilości tkanki do postawienia diagnozy.12

Paracenteza

Paracenteza to procedura, w której wprowadza się igłę przez skórę do jamy brzusznej w celu pobrania płynu. Jest to szczególnie przydatne, gdy w jamie brzusznej gromadzi się płyn (wodobrzusze), co jest częstym objawem zaawansowanego raka jajnika. Pobrany płyn bada się pod kątem obecności komórek nowotworowych.12

Ocena zaawansowania nowotworu

Po potwierdzeniu diagnozy raka jajnika, określa się stadium zaawansowania nowotworu. Stadium określa, jak duży jest guz i jak daleko rozprzestrzenił się nowotwór.12

Najczęściej stosowany system oceny zaawansowania raka jajnika to system Międzynarodowej Federacji Ginekologii i Położnictwa (FIGO). Wyróżnia się cztery główne stadia:12

  • Stadium I: Nowotwór ograniczony do jajników
  • Stadium II: Nowotwór zajmuje jeden lub oba jajniki i rozprzestrzenił się na inne tkanki w obrębie miednicy (macica, jajowody)
  • Stadium III: Nowotwór rozprzestrzenił się poza miednicę do innych części jamy brzusznej lub do węzłów chłonnych
  • Stadium IV: Nowotwór rozprzestrzenił się do odległych narządów, takich jak wątroba czy płuca

Określenie stadium zaawansowania nowotworu jest kluczowe dla zaplanowania odpowiedniego leczenia. Leczenie zazwyczaj obejmuje operację chirurgiczną w celu usunięcia jak największej ilości nowotworu, a następnie chemioterapię.12

Nowe kierunki w diagnostyce raka jajnika

Badania nad nowymi metodami diagnostycznymi raka jajnika są prowadzone na całym świecie. Niektóre obiecujące kierunki to:123

  • Biopsja płynna – badanie DNA nowotworowego krążącego we krwi
  • Sekwencjonowanie nowej generacji (NGS) – badanie mutacji genetycznych w komórkach nowotworowych
  • Sztuczna inteligencja w analizie obrazów medycznych
  • Nanotechnologia – nowe metody wykrywania markerów nowotworowych z wysoką czułością
  • Kombinacje biomarkerów – zamiast pojedynczych markerów

Naukowcy z Georgia Tech Integrated Cancer Research Center opracowali nowy test diagnostyczny łączący uczenie maszynowe z informacjami o metabolitach we krwi, który wykrywa raka jajnika z 93% dokładnością. Test ten ma potencjał do wcześniejszego wykrywania choroby, kiedy leczenie jest bardziej skuteczne.123

Innym obiecującym kierunkiem jest test CLEO Triage Test opracowany przez Hudson Institute of Medical Research, który wykorzystuje nowy biomarker CXCL10 produkowany wcześnie i w dużych ilościach przez komórki raka jajnika. Test ten ma potencjał do dokładniejszego różnicowania między łagodnymi a złośliwymi zmianami bez konieczności interwencji chirurgicznej.123

Podsumowanie diagnostyki raka jajnika

Diagnostyka raka jajnika pozostaje wyzwaniem ze względu na brak skutecznych metod wczesnego wykrywania i niespecyficzne objawy we wczesnych stadiach choroby. Obecnie proces diagnostyczny obejmuje kombinację badań, w tym:12

  • Badanie ginekologiczne
  • Badania obrazowe (USG, CT, MRI, PET)
  • Badania krwi (markery nowotworowe, szczególnie CA-125)
  • Biopsję (zazwyczaj podczas zabiegu chirurgicznego)
  • Badania genetyczne

Biopsja pozostaje jedynym definitywnym sposobem potwierdzenia diagnozy raka jajnika. Wczesna i dokładna diagnoza ma kluczowe znaczenie dla poprawy rokowania. Pięcioletnie wskaźniki przeżycia w zależności od stadium choroby wynoszą:12

  • Stadium I: około 93%
  • Stadium II: około 74%
  • Stadium III: około 41%
  • Stadium IV: około 20%

Podkreśla to znaczenie wczesnego wykrywania i diagnostyki raka jajnika. Trwające badania nad nowymi metodami diagnostycznymi dają nadzieję na poprawę wczesnego wykrywania tego nowotworu w przyszłości.12

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Diagnosis and Management of Ovarian Cancer | AAFP
    https://www.aafp.org/pubs/afp/issues/2016/0601/p937.html
    Ovarian cancer is the most lethal gynecologic cancer. Less than one-half of patients survive for more than five years after diagnosis. Ovarian cancer affects women of all ages but is most commonly diagnosed after menopause. More than 75% of affected women are diagnosed at an advanced stage because early-stage disease is usually asymptomatic and symptoms of late-stage disease are nonspecific. Women who have symptoms concerning for ovarian cancer should undergo a physical examination, transvaginal ultrasonography, and measurement of biomarkers such as cancer antigen 125. If results are suspicious for ovarian cancer, the patient should be referred to a gynecologic oncologist. […] Despite the low rate of early diagnosis, guidelines recommend against routine screening for ovarian cancer in average-risk women because screening, including routine pelvic examinations, is ineffective and associated with harm.
  • #1 How is Ovarian Cancer Detected? | OCRA
    https://ocrahope.org/for-patients/gynecologic-cancers/ovarian-cancer/detection-diagnosis/
    If a doctor suspects ovarian cancer, they may perform tests such as a pelvic exam, transvaginal ultrasound, CT scan, or CA-125 blood test to learn more. […] A surgical biopsy is the only way to make a definitive diagnosis of ovarian cancer. […] Ovarian cancer also cannot be diagnosed through a Pap smear, which only screens for cervical cancer. […] However, a surgical biopsy is the only definitive way to diagnose ovarian cancer. […] A surgical biopsy is the only way to definitively diagnose ovarian cancer. […] The only way to definitively determine if a patient has ovarian cancer is through a biopsy. […] CA-125 blood test, or Cancer Antigen 125 is a test that measures a protein that is elevated in more than 80% of advanced ovarian cancers and 50% of early-stage cancers. […] Although a CA-125 blood test can be a useful tool for the diagnosis of ovarian cancer, it is not uncommon for a CA-125 count to be elevated in premenopausal women due to benign conditions since it fluctuates as part of their normal menstrual cycle, or due to benign conditions unrelated to ovarian cancer, such as diverticulitis, endometriosis, liver cirrhosis, pregnancy, or uterine fibroids. […] The CA-125 test is most helpful in postmenopausal women with a pelvic mass. […] For these reasons, the National Cancer Institute and the United States Preventive Services Task Force do not endorse using it to screen women for ovarian cancer who are at ordinary risk or in the general population.
  • #1 Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9221480/
    Here, we present a detailed review of the overall landscape of ovarian cancer diagnostics, with emphasis on emerging methods that employ novel protein, genetic, epigenetic and imaging-based biomarkers and/or advanced diagnostic technologies for the noninvasive detection of HGSC, particularly in women at high risk due to germline mutations such as BRCA1/2. […] Consequently, the long-term survival rate for women diagnosed with ovarian cancer remains low, with a 5-year survival rate of only 49%. […] Unfortunately, in the case of HGSC, effective screening remains unavailable, as there is currently no strategy for early detection screening that reduces mortality or incidence of ovarian cancer. […] As a consequence, routine screening for HGSC is, at present, not recommended by the United States Preventative Services Task Force (USPSTF) due to the fact that the potential harms outweigh the potential benefits.
  • #1 Screening for Ovarian Cancer | Ovarian Cancer | CDC
    https://www.cdc.gov/ovarian-cancer/screening/index.html
    There is no reliable way to screen for ovarian cancer in women who do not have any symptoms. […] There are no screening tests for ovarian cancer in women who do not have any signs or symptoms. The Pap test does not screen for ovarian cancer. […] Diagnostic tests are used when a person has symptoms. The purpose of diagnostic tests is to find out, or diagnose, what is causing the symptoms. […] Ask your doctor if you should have a diagnostic test, like a rectovaginal pelvic exam, a transvaginal ultrasound, or a CA-125 blood test if you have any unexplained signs or symptoms of ovarian cancer. These tests sometimes help find or rule out ovarian cancer.
  • #1 Ovarian Cancer: Symptoms, Diagnosis & Treatment
    https://my.clevelandclinic.org/health/diseases/4447-ovarian-cancer
    Ovarian cancer is sometimes difficult to detect because symptoms often dont develop until later stages. […] Despite years of research, experts havent yet developed a successful ovarian cancer screening test. For this reason, the condition is often difficult to diagnose in the early stages. […] If your healthcare provider suspects ovarian cancer, theyll ask about your symptoms and perform a pelvic exam. During the exam, theyll check for any abnormal growths or enlarged organs. […] Blood tests look for a substance called CA-125. High levels of CA-125 in your blood can be a sign of cancer. However, CA-125 levels can be normal, even when cancer is present, and higher in many conditions that arent cancer. Because of this, providers use blood tests in combination with other tests to diagnose ovarian cancer.
  • #1 Detection – Ovarian Cancer Canada
    https://ovariancanada.org/detection
    Ovarian cancer is notoriously difficult to detect. There is no effective screening test for this disease. […] Ovarian cancer is difficult to diagnose for several reasons: There is no screening test for ovarian cancer, and there is no single reliable diagnostic test for ovarian cancer. […] Significant global cancer research is underway to develop a reliable screening test to detect ovarian cancer in its early stages. However, at this time, there is not a single test that is sensitive enough to detect ovarian cancer in its earliest stages. […] If you have any symptoms of ovarian cancer that are abnormal for you and persist for 3 or more weeks, you should speak with your doctor expressing that you are concerned about ovarian cancer. The following tests can be performed: […] If ovarian cancer is suspected, you should be referred to a gynecologic oncologist for diagnosis through surgical biopsy. Your surgery must be performed by a gynecologic oncologist, as these doctors are specialized in ovarian cancer.
  • #1 Patient education: Ovarian cancer diagnosis and staging (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/ovarian-cancer-diagnosis-and-staging-beyond-the-basics
    Patient education: Ovarian cancer diagnosis and staging (Beyond the Basics) […] This topic review will discuss the diagnosis and staging of epithelial ovarian cancer. […] If ovarian cancer is suspected based on symptoms and/or an abnormal physical examination, imaging tests of the abdomen and pelvis are usually recommended as an initial step in the evaluation. Imaging tests may include ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI). These tests do not provide enough information by themselves to definitively diagnose ovarian cancer, although they may provide important information about the location and/or extent of a possible cancer. […] The only way to diagnose ovarian cancer with certainty is through surgery (see 'Initial surgery’ below). […] Tumor markers (CA 125) — While there is no blood test that can definitively diagnose ovarian cancer, a blood test called CA 125 may be done when cancer is suspected.
  • #1 Diagnosis of ovarian cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/ovarian/diagnosis
    Diagnosis is the process of finding out the cause of a health problem. Diagnosing ovarian cancer usually begins with a visit to your family doctor. Your doctor will ask you about any symptoms you have and do a physical exam. Based on this information, your doctor may refer you to a specialist or order tests to check for ovarian cancer or other health problems. […] The following tests are usually used to rule out or diagnose ovarian cancer. Many of the same tests used to diagnose cancer are used to find out the stage (how far the cancer has progressed). Your doctor may also order other tests to check your general health and to help plan your treatment. […] A physical exam allows your doctor to look for signs of ovarian cancer. During a physical exam, your doctor may: do a pelvic and rectal exam to check the uterus, vagina, ovaries, fallopian tubes, bladder and rectum for any unusual changes.
  • #1 Ovarian cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/ovarian-cancer/diagnosis-treatment/drc-20375946
    During a pelvic exam, a doctor inserts one or two gloved fingers inside the vagina. Pressing down on the abdomen at the same time, the doctor can check the uterus, ovaries and other organs. […] Tests and procedures used to diagnose ovarian cancer include: […] Blood tests might include organ function tests that can help determine your overall health. Your doctor might also test your blood for tumor markers that indicate ovarian cancer. For example, a cancer antigen (CA) 125 test can detect a protein that’s often found on the surface of ovarian cancer cells. These tests can’t tell your doctor whether you have cancer, but they may provide clues about your diagnosis and prognosis. […] Sometimes your doctor can’t be certain of your diagnosis until you undergo surgery to remove an ovary and have it tested for signs of cancer.
  • #1 Ovarian Cancer Diagnosis and How to Test
    https://www.cancercenter.com/cancer-types/ovarian-cancer/diagnosis-and-detection
    While women of any age may develop ovarian cancer, its most commonly diagnosed in postmenopausal women between the ages of 55 and 64. In 2025, approximately 20,890 U.S. women will receive an ovarian cancer diagnosis, according to the American Cancer Society. […] Finding an appropriate treatment plan starts with an accurate diagnosis. Gynecologic oncologists use a variety of tools to diagnose ovarian cancer and determine the type and stage of the disease. […] Detecting ovarian cancer through a pelvic exam alone is rare, especially in the early stages of the disease. Other diagnostic tests may be necessary. […] A transvaginal ultrasound is typically the first type of imaging test used if any issues with the ovaries are suspected. […] A screening test for ovarian cancer hasnt yet been developed. In early cases, ovarian cancer may go undetected even with a transvaginal ultrasound.
  • #1 Diagnosis of ovarian cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/ovarian/diagnosis
    An ultrasound uses high-frequency sound waves to make images of parts of the body. A pelvic or transvaginal ultrasound may be done to look for ovarian cancer. […] Tumour marker tests are generally used to check your response to cancer treatment and watch for recurrences. They can also be helpful when diagnosing ovarian cancer. […] A CBC is done to provide information about your general health, check for anemia from long-term vaginal bleeding and to provide a baseline to compare with future CBCs during and after treatment. […] A CT scan is used to: assess the pelvis, abdomen and lymph nodes around the ovaries; see if cancer has spread to other organs or tissues; guide the needle when doing a biopsy of an area of suspected metastasis. […] An MRI is used to: assess the pelvis, abdomen and lymph nodes around the ovaries; see if cancer has spread to other organs or tissues; guide the needle when doing a biopsy of an area of suspected metastasis.
  • #1 Ovarian Cancer Diagnosis | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/cancer-care/types/ovarian/diagnosis
    Ovarian Cancer Diagnosis […] To check for ovarian cancer, your doctor will likely perform a pelvic exam to feel for lumps or changes in and around the ovaries, and order additional tests if you’ve been experiencing persistent abdominal bloating, discomfort or other symptoms, or if you have risk factors for ovarian cancer. […] The following tests and procedures can help determine if you have ovarian, fallopian tube, or peritoneal cancer (the peritoneum is a layer of tissue that lines your abdomen). They can also help in determining the stage of the cancer, and build a treatment plan specifically for you. […] Following a pelvic exam, we may recommend you undergo imaging tests such as transvaginal ultrasound, which is considered more accurate than a traditional ultrasound test because it allows technicians to place a special kind of wand called a transducer into the vagina and physically close to the ovaries. […] A simple blood test to measure the level of the CA-125 protein can be helpful in making a diagnosis. […] For many women, surgical procedures such as minimally invasive laparoscopy and robotic surgery are used to remove a sample of tissue for pathologists to determine if cancer is present.
  • #1 Ovarian Cancer: Diagnosis
    https://healthlibrary.ecuhealth.org/library/TestsProcedures/Gynecology/34,17187-1
    Ultrasound […] This is also called a sonogram. It allows your healthcare provider to look for cysts or tumors on your ovaries. It also shows if there’s fluid in your abdomen. A small, wand-like probe is put into your vagina (transvaginal ultrasound). Or the probe is pressed against the skin of your abdomen (abdominal ultrasound). The probe sends out the sound waves. They bounce off your inside tissues, and the pattern of the echoes makes a picture on a video screen. The echoes change for healthy tissues, fluid-filled cysts, and tumors. The test can be uncomfortable, but it doesnt hurt. It doesnt use X-rays. […] CT scan […] This test makes detailed 3-D pictures of organs and tissues in your pelvis, abdomen, or both. An X-ray machine linked to a computer takes many pictures. You may get contrast dye by mouth, as a shot, or both into your arm or hand. The dye helps your organs and tissues show up more clearly.
  • #1 Testing for Ovarian Cancer: Getting an Ovarian Cancer Diagnosis
    https://www.health.com/ovarian-cancer-diagnosis-6891208
    Detecting ovarian cancer through pelvic exams is rare in the early stages of the disease. Most tumors will be too small to feel. […] Imaging tests send forms of energy (e.g., sound waves, radioactive particles) to take pictures of the inside of your body. […] A transvaginal ultrasound uses sound waves to produce pictures of the pelvic organs and structures. […] An ultrasound can provide an estimated size of the mass and determine if it’s solid (tumor) or fluid-filled (cyst). […] Computed tomography (CT) scans use X-rays to create cross-sectional images of your abdomen or pelvis. A CT scan can help diagnose ovarian cancer, but it’s more often used to see if the cancer has spread (metastasized). […] A healthcare provider may use a CT scan to guide a needle biopsy. […] Magnetic resonance imaging (MRI) scans produce cross-section pictures of your body. An MRI scan is a highly accurate way to see if a mass is malignant or benign.
  • #1 Diagnosis of ovarian cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/ovarian/diagnosis
    During a biopsy, the doctor removes tissues or cells from the body so they can be tested in a lab. A report from the pathologist will show whether or not cancer cells are found in the sample. […] A paracentesis is a procedure in which a hollow needle or tube is inserted through the skin and into the abdominal cavity. This procedure is done to remove symptomatic buildup of fluid in the abdomen (ascites). The fluid is examined for cancer cells. […] A colonoscopy may be done to see if the ovarian cancer has spread to the colon or to rule out colon cancer. […] A PET scan may be used to find ovarian cancer that has come back or has spread to other organs or tissues.
  • #1 Automated early ovarian cancer detection system based on bioinformatics | Scientific Reports
    https://www.nature.com/articles/s41598-024-71863-9
    At present, the main diagnostic methods for ovarian cancer are serum testing and B-ultrasound examination. […] Although positive patients with ovarian cancer can be detected to a certain extent, the sensitivity and specificity of early diagnosis are not high. […] Serum CA125 detection is the main early detection method, which achieves early ovarian cancer detection by measuring CA125 levels. […] This article integrates PET/CT with serum CA125 detection to achieve automated early ovarian cancer detection and improve the early diagnostic efficiency of ovarian cancer patients. […] Early detection of ovarian cancer has important clinical value. […] Early detection of ovarian cancer can reduce patient mortality, but a single serum CA125 test is ineffective and lacks the use of medical images to assist in early ovarian cancer detection.
  • #1 Ovarian cancer | Macmillan Cancer Support
    https://www.macmillan.org.uk/cancer-information-and-support/ovarian-cancer
    Chemotherapy uses anti-cancer (cytotoxic) drugs to destroy cancer cells. […] You usually have more chemotherapy and a targeted therapy drug. […] After treatment, you will have regular check-ups. These are usually every few months to start with. […] CA125 blood tests are sometimes done as part of your follow-up. But this is not always needed. A rising CA125 level may be a sign that the cancer has returned. […] Your specialist nurse can give you support and explain what symptoms to look out for.
  • #1 Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9221480/
    Despite this fact, the clinical need for accurate screening and diagnostic tests for OC remains urgent. […] The current clinically available approaches for OC screening are primarily limited to physical assessment by clinicians, imaging of the adnexa by transvaginal ultrasound (TVU), and serum level measurements of protein biomarker cancer antigen 125 (CA125). […] CA125, the most widely used OC biomarker, is an epithelial cell surface glycoprotein that is implicated in promoting cancer cell growth and metastasis. […] Unfortunately, further investigations into the clinical benefit of CA125 screening have yet to demonstrate substantial benefit to patients, primarily due to a lack of clinical sensitivity for CA125 at the early stages of disease. […] Despite its poor performance as a screening biomarker, CA125 does show clinical benefit for patients when used as a post-operative marker for monitoring patient response to therapy and facilitates detection of recurrent disease.
  • #1 Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9221480/
    Discussed in the following sections of this review are emerging diagnostic and screening strategies for early-stage detection of HGSC. […] The clinical performance of OVA1 was evaluated in a number of clinical trials. […] While the high sensitivity of OVA1 in combination with physician assessment is beneficial, in that many women who do have ovarian cancer are sent for surgical follow-up, the low specificity would nominally result in a large number of women without disease being sent for unnecessary surgical evaluations. […] The second FDA-cleared protein biomarker assay for preoperative adnexal mass assessment is the Ovarian Risk of Malignancy Algorithm (ROMA), developed by Fujirebio Diagnostics Inc., Tokyo, Japan, which received its clearance in 2010. […] Overall, while OVA1, Overa, and ROMA tests are currently FDA-cleared for assessing epithelial ovarian cancer individually, they are not intended to be used as a screening or stand-alone diagnostic test and should not be used without additional imaging or clinical evaluations. […] The development of methods specifically designed for detecting early-stage disease and even precursor STIC lesions through minimally invasive means would be the most impactful for patients.
  • #1 Tests for Ovarian Cancer | How Is Ovarian Cancer Diagnosed? | American Cancer Society
    https://www.cancer.org/cancer/types/ovarian-cancer/detection-diagnosis-staging/how-diagnosed.html
    In some ovarian cancers, doctors might look for specific gene or protein changes in the cancer cells that could mean certain targeted or immunotherapy drugs might help treat the cancer. […] Ovarian cancers with BRCA gene mutations are more likely to be helped by treatment with targeted drugs called PARP inhibitors. […] Testing might also be done to see if the cancer cells have changes in any of the mismatch repair (MMR) genes (MLH1, MSH2, MSH6, and PMS2). […] Ovarian cancers that have certain MSI or MMR gene changes might be treated with certain immunotherapy drugs known as checkpoint inhibitors.
  • #1 How is ovarian cancer diagnosed? | Cancer Australia
    https://www.canceraustralia.gov.au/cancer-types/ovarian-cancer/how-ovarian-cancer-diagnosed
    The only way to confirm a diagnosis of ovarian cancer is through a biopsy, usually done by surgery. During surgery, the doctor takes a biopsy – where a small sample of tissue is removed to be examined under a microscope. The surgeon will also take samples of any fluid in the abdomen. These samples will be used to stage the cancer. […] Ovarian cancer is surgically staged, based on the extent of the cancer. Knowing the stage of the disease helps your medical team plan the best treatment for you. […] Women who have been diagnosed with epithelial ovarian cancer should have their genetic risk assessed. These women may be offered genetic testing if they meet certain clinical, personal and/or family history criteria.
  • #1
    https://winshipcancer.emory.edu/cancer-types-and-treatments/ovarian-cancer/diagnosis.php
    The only way to determine whether a growth on the ovary is cancerous is to remove a sample of the tumor (biopsy) and test it in the lab. It is often the case with suspected ovarian cancer that it is performed via surgery at the same time the tumor is removed. […] If your team determines that your tumor is cancerous, our molecular pathologists will conduct genomic profiling to look at the DNA inside your tumor to identify any biomarkers and genetic mutations, or cell characteristics. Winship scientists, genomic- and tumor-sequencing experts will analyze whats driving your particular form of ovarian cancer and then work with your oncologists to determine which treatment types are most likely to work for you. […] Because up to a quarter of all ovarian cancers are caused by inherited traits, Winship refers everyone who is diagnosed with ovarian cancer for genetic counseling and if desired genetic testing. Genetic testing can help your physicians design a more informed treatment plan, select the right targeted therapy for your cancer, and prevent recurrence and the development of other cancers. The information can even help you protect your family members from ovarian cancer. […] We want to give you an accurate ovarian cancer diagnosis so you can get the most effective treatment possible. Winship welcomes patients from near and far for diagnostic services and will share with you and your doctors our recommended treatment plan whether you decide to get treated here or not.
  • #1 Ovarian Cancer Diagnosis – ovarian.org
    https://ovarian.org/about-ovarian-cancer/ovarian-cancer-diagnosis/
    An initial ovarian cancer diagnosis often begins with symptoms, such as bloating or pelvic pain. But ovarian cancer does not always have symptoms in the early stages. Only 20% of ovarian cancers are diagnosed in the early stages. Most patients, between 70% to 80%, have stage III or stage IV ovarian cancer by the time they see a doctor. […] A biopsy is the only way to definitively diagnose ovarian cancer. A biopsy removes tissue or cell samples for a pathologist to examine. […] Ovarian cancer is diagnosed through a combination of medical history review, physical examination, imaging tests, and laboratory tests. […] If any test returns an abnormal result, it is recommended to see an ovarian cancer specialist, ideally a gynecologic oncologist. They will evaluate the test results and may order other tests to see if there are concerns of cancer.
  • #1 Testing for ovarian cancer | Ovarian Cancer Information | Ovarian Cancer Action
    https://ovarian.org.uk/ovarian-cancer/testing-for-ovarian-cancer/
    If your CA125 levels are elevated, your GP will refer to the radiology department of your local hospital for an ultrasound scan. […] A CT scan is a test that takes detailed pictures of the inside of your body. In the case of ovarian cancer, a CT scan may be recommended to find out if symptoms you have been experiencing are caused by something more serious. […] A fine needle biopsy is where the doctor passes a fine needle through the skin using a CT or ultrasound to guide them into the right place. […] A laparoscopy (otherwise known as keyhole surgery) biopsy is done under general anaesthetic. […] Another option to detect ovarian cancer could be to have an operation called a laparotomy to get a biopsy. […] In a pelvic examination, a doctor will press gently on different parts of the outside of your abdomen to feel for any masses or lumps.
  • #1 Patient education: Ovarian cancer diagnosis and staging (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/ovarian-cancer-diagnosis-and-staging-beyond-the-basics
    Initial surgery — A surgical procedure called exploratory laparotomy is typically recommended when ovarian cancer is suspected. […] During the procedure, the surgeon makes an abdominal incision (usually vertically) and examines the organs within the pelvis and abdomen for signs of cancer. […] If the pathologist finds evidence of ovarian cancer on frozen section analysis, the surgeon will then attempt to remove as much of the cancerous tissue as possible. This procedure is termed surgical staging and is an important first step in the treatment of ovarian cancer. […] Based upon the findings during exploratory surgery, the tumor is formally „staged” according to the size, extent, and location of the cancer, as well as how aggressive the tumor is (also referred to as the „grade” of the tumor). Accurate staging during surgery is very important in order to understand the long-term outcome (prognosis) and whether a person is a candidate for additional treatment after surgery. […] Recommendations for treatment after surgery depend upon the disease stage. While a course of chemotherapy is recommended after (or occasionally before) surgery for anyone with stage III or IV ovarian cancer, it may or may not be recommended for treatment of stage I or II disease.
  • #1 Ovarian cancer – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/ovarian-cancer/diagnosis-treatment/drc-20375946
    Once it’s confirmed that you have ovarian cancer, your doctor will use information from your tests and procedures to assign your cancer a stage. The stages of ovarian cancer range from 1 to 4, which are often indicated with Roman numerals I to IV. The lowest stage indicates that the cancer is confined to the ovaries. By stage 4, the cancer has spread to distant areas of the body.
  • #1 Diagnosis and Stages of Ovarian Cancer – Brigham and Women’s Hospital
    https://www.brighamandwomens.org/cancer/ovarian-cancer/diagnosis-and-stages-ovarian-cancer?TRILIBIS_EMULATOR_UA=…%3Fcmp%3Dhrgn%3Fcmp%3Dhrgn%2Caqkljlpwmmk%2F1000
    The stages of epithelial ovarian cancer are: […] Stage I: The cancer is in one or both of the ovaries. Cancer cells may be growing on the surface of the ovaries, inside the ovaries or in fluid that surrounds the abdomen. […] Stage II: The cancer is in one or both ovaries and in other areas in the pelvis. Cancer cells may be in the fallopian tubes, uterus or other areas in the pelvis and in the tissue or fluid that surrounds the abdomen. […] Stage III: The cancer has spread from the ovaries to the abdomen or nearby lymph nodes. Cancer cells may also have spread to the outside of the liver. […] Stage IV: The cancer has spread to other areas of the body, such as the as the liver, the lungs or in the fluid around the lungs.
  • #1 Researchers Leverage AI to Develop Early Diagnostic Test for Ovarian Cancer | News Center
    https://news.gatech.edu/news/2024/01/29/researchers-leverage-ai-develop-early-diagnostic-test-ovarian-cancer
    The Georgia Tech Integrated Cancer Research Center has combined machine learning with information on blood metabolites to develop a new early diagnostic test that detects ovarian cancer with 93 percent accuracy. […] Now, scientists in the Georgia Tech Integrated Cancer Research Center (ICRC) have combined machine learning with information on blood metabolites to develop a new test able to detect ovarian cancer with 93 percent accuracy among samples from the teams study group. […] John McDonald, professor emeritus in the School of Biological Sciences, founding director of the ICRC, and the studys corresponding author, explains that the new tests accuracy is better in detecting ovarian cancer than existing tests for women clinically classified as normal, with a particular improvement in detecting early-stage ovarian disease in that cohort.
  • #1 New more accurate ovarian cancer blood test: Hudson Institute
    https://www.hudson.org.au/news/melbourne-team-on-the-verge-of-a-more-accurate-test-for-ovarian-cancer/
    A new blood test is now being developed to improve ovarian cancer diagnosis, with the potential to reduce unnecessary surgery leading to better health outcomes, saving time, stress and money for patients and the healthcare system. […] Hudson Institute of Medical Research, funded by the Ovarian Cancer Research Foundation (OCRF), has developed a new diagnostic test for ovarian cancer, which is now being commercialised by ASX-bound Australian company Cleo Diagnostics Ltd. […] The blood tests will be underpinned by a patented novel biomarker, CXCL10, which is produced early and at high levels by ovarian cancers, but not in non-malignant disease. […] Initial clinical use will focus on the surgical triage market to improve treatment outcomes for patients with ovarian cancer, and simultaneously avoid unnecessary surgery and anxiety for women with far more common non-cancerous conditions.
  • #1 Early Diagnosis of Ovarian Cancer: A Comprehensive Review of the Advances, Challenges, and Future Directions
    https://www.mdpi.com/2075-4418/15/4/406
    Approximately 66% of patients are diagnosed at advanced stages, International Federation of Gynecology and Obstetrics or “FIGO” stage III or IV, which have a 5-year survival rate of 41% and 20%, respectively. Conversely, the 5-year survival rates for stages I and II are approximately 93% and 74%, respectively. Therefore, early-stage detection and treatment of OC are vital. […] However, OC often presents with vague and non-specific symptoms, challenging its early detection. […] The main symptoms associated with advanced-stage OC are bloating (77%), increased abdominal size (64%), abdominal pain (22%), constipation (24%), back pain (45%), pelvic pain (26%), fatigue (34%), and urinary urgency or frequency (16–34%). […] This review highlights the critical need for continued research and innovation to enhance early diagnosis, reduce mortality, and improve patient outcomes in OC and posits personalized medicine, integrated emerging technologies, and targeted global initiatives and collaborative efforts, which address care access disparities and promote cost-effective, scalable screening strategies, as potential tools to combat OC.
  • #2 Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9221480/
    Ovarian high-grade serous carcinoma (HGSC) has a 5-year survival rate of less than 50%, making it one of the most lethal gynecological cancers for women in the developed world today. […] Early detection is associated with significant improvements in survival, however, screening in the general population is currently not recommended at this time due to a notable lack of sensitive and specific biomarkers for early-stage disease. […] There are currently no recommended screening tests for ovarian cancer and there thus remains an urgent need for new diagnostic methods, particularly those that can detect the disease at early stages when clinical intervention remains effective. […] While diagnostics for ovarian cancer share many of the same technical hurdles as for other cancer types, the low prevalence of the disease in the general population, coupled with a notable lack of sensitive and specific biomarkers, have made the development of a clinically useful screening strategy particularly challenging.
  • #2 Ovarian Cancer Diagnosis – ovarian.org
    https://ovarian.org/about-ovarian-cancer/ovarian-cancer-diagnosis/
    Getting a diagnosis of ovarian cancer can be overwhelming. Fortunately, there are programs and resources to help. There are also support groups available for patients and caregivers. […] If symptoms do not go away within two weeks following normal interventions such as laxatives, rest, or changing diet and exercise, contact your doctor. Your doctor will look at your medical history, including your family medical history. This will help them learn about any risk factors you might have. Your doctor will ask about your symptoms, including when they started and how long you’ve had them. If your symptoms and medical history suggest ovarian cancer, your doctor will order further testing. […] A Pap smear or test is a common procedure to screen for cervical cancer. It does not detect ovarian cancer.
  • #2 Diagnosis and Management of Ovarian Cancer | AAFP
    https://www.aafp.org/pubs/afp/issues/2016/0601/p937.html
    Surgery is the primary treatment for ovarian cancer. It is used for staging and cytoreduction (debulking), but it is potentially curative in disease confined to the ovaries. […] Transvaginal ultrasonography and CA 125 testing are the two most studied ovarian cancer screening modalities. A U.S. clinical trial found that using these tests to screen average-risk women did not decrease mortality risk and was associated with increased harms, but a U.K. trial reported a benefit of screening with no substantially increased harms. […] The USPSTF and the AAFP recommend against routine screening for ovarian cancer in asymptomatic women, but recommend that women with a high-risk family history be offered referral for genetic counseling and, if appropriate, genetic testing.
  • #2 Ovarian cancer | Macmillan Cancer Support
    https://www.macmillan.org.uk/cancer-information-and-support/ovarian-cancer
    Your specialist doctor will usually ask about your general health, any previous health problems, and any history of cancer in your family. […] Your doctor may use your test results to check your Risk of Malignancy Index (RMI) score. This system checks how likely it is your symptoms are caused by cancer. […] Your specialist doctor arranges further tests. These help to diagnose the cancer and plan your treatment. […] A CT scan takes a series of x-rays, which build up a 3D picture of the inside of the body. […] Sometimes swelling in the tummy is caused by a build-up of fluid. This is called ascites. If you have ascites your doctor may want to take a sample of this fluid and test it for cancer cells. […] A biopsy is when the doctor removes a small sample of tissue (biopsy) from the lump or abnormal area. The sample is sent to the laboratory and examined under a microscope.
  • #2 Diagnosis of ovarian cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/ovarian/diagnosis
    Diagnosis is the process of finding out the cause of a health problem. Diagnosing ovarian cancer usually begins with a visit to your family doctor. Your doctor will ask you about any symptoms you have and do a physical exam. Based on this information, your doctor may refer you to a specialist or order tests to check for ovarian cancer or other health problems. […] The following tests are usually used to rule out or diagnose ovarian cancer. Many of the same tests used to diagnose cancer are used to find out the stage (how far the cancer has progressed). Your doctor may also order other tests to check your general health and to help plan your treatment. […] A physical exam allows your doctor to look for signs of ovarian cancer. During a physical exam, your doctor may: do a pelvic and rectal exam to check the uterus, vagina, ovaries, fallopian tubes, bladder and rectum for any unusual changes.
  • #2 Tests for Ovarian Cancer | How Is Ovarian Cancer Diagnosed? | American Cancer Society
    https://www.cancer.org/cancer/types/ovarian-cancer/detection-diagnosis-staging/how-diagnosed.html
    Medical history and physical exam […] If there is reason to suspect you might have ovarian cancer based on your symptoms and/or physical exam, your doctor will order some tests to check further. […] If the results of your pelvic exam or other tests suggest that you might have ovarian cancer, you will need a doctor or surgeon who specializes in treating women with this type of cancer. […] Imaging tests can show whether a pelvic mass is present, but they cannot confirm that the mass is a cancer. […] Ultrasound is often the first test done if a problem with the ovaries is suspected. […] The CT scan is an x-ray test that makes detailed cross-sectional images of your body. […] MRI scans are not used often to look for ovarian cancer, but they are particularly helpful to examine the brain and spinal cord where cancer could spread.
  • #2 Ovarian Cancer: Symptoms, Diagnosis & Treatment
    https://my.clevelandclinic.org/health/diseases/4447-ovarian-cancer
    Ovarian cancer is sometimes difficult to detect because symptoms often dont develop until later stages. […] Despite years of research, experts havent yet developed a successful ovarian cancer screening test. For this reason, the condition is often difficult to diagnose in the early stages. […] If your healthcare provider suspects ovarian cancer, theyll ask about your symptoms and perform a pelvic exam. During the exam, theyll check for any abnormal growths or enlarged organs. […] Blood tests look for a substance called CA-125. High levels of CA-125 in your blood can be a sign of cancer. However, CA-125 levels can be normal, even when cancer is present, and higher in many conditions that arent cancer. Because of this, providers use blood tests in combination with other tests to diagnose ovarian cancer.
  • #2 Ovarian Cancer Diagnosis | NYU Langone Health
    https://nyulangone.org/conditions/ovarian-cancer/diagnosis
    Ovarian Cancer Diagnosis […] If your symptoms as well as the results of a physical exam and imaging tests suggest you might have ovarian cancer, your gynecologist can refer you to a gynecologic oncologist right away. […] A gynecologic oncologist is a doctor who completes specialized training in diagnosing and treating cancers that develop in a womans reproductive organs. […] It is important to consult with a gynecologic oncologist before treatment starts so that the best approach to cancer care can be recommended to you. […] To help diagnose ovarian cancer, our doctors may order imaging tests and blood tests. […] If ovarian cancer is suspected, our doctor may also perform a biopsythe removal of tissue for examination under a microscope for signs of cancerduring surgery. […] A CT scan is a form of X-ray in which a computer creates cross-sectional, three-dimensional pictures of the body.
  • #2 Testing for Ovarian Cancer: Getting an Ovarian Cancer Diagnosis
    https://www.health.com/ovarian-cancer-diagnosis-6891208
    Detecting ovarian cancer through pelvic exams is rare in the early stages of the disease. Most tumors will be too small to feel. […] Imaging tests send forms of energy (e.g., sound waves, radioactive particles) to take pictures of the inside of your body. […] A transvaginal ultrasound uses sound waves to produce pictures of the pelvic organs and structures. […] An ultrasound can provide an estimated size of the mass and determine if it’s solid (tumor) or fluid-filled (cyst). […] Computed tomography (CT) scans use X-rays to create cross-sectional images of your abdomen or pelvis. A CT scan can help diagnose ovarian cancer, but it’s more often used to see if the cancer has spread (metastasized). […] A healthcare provider may use a CT scan to guide a needle biopsy. […] Magnetic resonance imaging (MRI) scans produce cross-section pictures of your body. An MRI scan is a highly accurate way to see if a mass is malignant or benign.
  • #2 Automated early ovarian cancer detection system based on bioinformatics | Scientific Reports
    https://www.nature.com/articles/s41598-024-71863-9
    Early ovarian cancer has no obvious physical manifestations, and traditional pathological, serum, and other treatment methods are difficult to accurately detect. […] Many people use medical imaging to detect early ovarian cancer. […] PET/CT detects and locates tumor tissue by injecting radiolabeled glucose, which is taken up by metabolically active cancer cells in the body, and then performing a full-body scan to generate accurate three-dimensional images. […] Combined with serum tumor marker testing, it can provide a more comprehensive disease assessment, help doctors develop more accurate treatment plans, and improve treatment outcomes. […] The combination of serum CA125 detection and PET/CT detection can effectively combine the advantages of both detection methods to achieve timely and early detection of ovarian cancer.
  • #2 Automated early ovarian cancer detection system based on bioinformatics | Scientific Reports
    https://www.nature.com/articles/s41598-024-71863-9
    The automated early ovarian cancer detection system designed in this article combines the advantages of serum detection and medical image detection. […] Automated early ovarian cancer detection can detect symptoms in the early stages of a patient’s onset, enabling early treatment of ovarian cancer, improving treatment effectiveness, and effectively ensuring patient safety. […] The automated early ovarian cancer detection system designed in this article has superior detection accuracy, sensitivity, and specificity compared to a single serum CA125 detection and a single PET/CT imaging and can accurately detect early ovarian cancer.
  • #2 Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9221480/
    Despite this fact, the clinical need for accurate screening and diagnostic tests for OC remains urgent. […] The current clinically available approaches for OC screening are primarily limited to physical assessment by clinicians, imaging of the adnexa by transvaginal ultrasound (TVU), and serum level measurements of protein biomarker cancer antigen 125 (CA125). […] CA125, the most widely used OC biomarker, is an epithelial cell surface glycoprotein that is implicated in promoting cancer cell growth and metastasis. […] Unfortunately, further investigations into the clinical benefit of CA125 screening have yet to demonstrate substantial benefit to patients, primarily due to a lack of clinical sensitivity for CA125 at the early stages of disease. […] Despite its poor performance as a screening biomarker, CA125 does show clinical benefit for patients when used as a post-operative marker for monitoring patient response to therapy and facilitates detection of recurrent disease.
  • #2 Tests for ovarian cancer | Cancer Research UK
    https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/getting-diagnosed/tests-ovarian-cancer
    There are a number of tests you might have to find out the cause of your symptoms. If you have ovarian cancer, you usually have further tests to find out how big the cancer is and whether it has spread. This might include all or some of the following: blood tests, ultrasound scan, taking a sample of tissue called a biopsy. […] Your GP can do some tests to help them decide whether you need to see a specialist. This usually includes: physical examination, blood tests including the CA125 blood test, ultrasound scan. […] You usually also have a blood test to check the levels of a protein called CA125. […] Most women have a low level of CA125 in their blood. It might be raised in women with some types of ovarian cancer. You may hear doctors calling CA125 a type of tumour marker. […] CA125 is not a completely reliable test for ovarian cancer. Some women with ovarian cancer will have a normal CA125 level. Some non cancerous conditions of the womb and ovaries can also raise the levels of CA125.
  • #2 Diagnosing Ovarian Cancer | Willamette Valley Cancer Institute
    https://www.oregoncancer.com/ovarian-cancer/diagnosis
    If you have a symptom that suggests ovarian cancer, your doctor must find out whether it is due to cancer or to some other cause. Your doctor may ask about your personal and family medical history, as well as have one or more of the following tests to diagnose ovarian cancer. […] Your doctor can explain more about each test: […] Physical exam: To check general signs of health. Your doctor may press on your abdomen to check for tumors or an abnormal buildup of fluid (ascites). A sample of fluid can be taken to look for ovarian cancer cells. […] Blood tests: To check the level of several substances, including CA-125, a substance found on the surface of ovarian cancer cells and on some normal tissues. A high CA-125 level can signal cancer or other conditions. The CA-125 test is not used alone to diagnose ovarian cancer. This test is approved by the Food and Drug Administration for monitoring a woman’s response to ovarian cancer treatment and for detecting its return after treatment.
  • #2 Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9221480/
    Discussed in the following sections of this review are emerging diagnostic and screening strategies for early-stage detection of HGSC. […] The clinical performance of OVA1 was evaluated in a number of clinical trials. […] While the high sensitivity of OVA1 in combination with physician assessment is beneficial, in that many women who do have ovarian cancer are sent for surgical follow-up, the low specificity would nominally result in a large number of women without disease being sent for unnecessary surgical evaluations. […] The second FDA-cleared protein biomarker assay for preoperative adnexal mass assessment is the Ovarian Risk of Malignancy Algorithm (ROMA), developed by Fujirebio Diagnostics Inc., Tokyo, Japan, which received its clearance in 2010. […] Overall, while OVA1, Overa, and ROMA tests are currently FDA-cleared for assessing epithelial ovarian cancer individually, they are not intended to be used as a screening or stand-alone diagnostic test and should not be used without additional imaging or clinical evaluations. […] The development of methods specifically designed for detecting early-stage disease and even precursor STIC lesions through minimally invasive means would be the most impactful for patients.
  • #2 How We Diagnose Ovarian Cancer | Dana-Farber Cancer Institute
    https://www.dana-farber.org/cancer-care/types/ovarian-cancer/diagnosis
    Up to 22 percent of ovarian, fallopian tube, and peritoneal cancers are caused by inherited gene mutations, such as the BRCA1 and BRCA2 genes and Lynch syndrome genes. Genetic testing is done to detect these mutated genes that can indicate a high risk of ovarian cancer. […] Information from exams and diagnostic tests is used to determine the extent of the tumor and whether the cancer has spread to the lymph nodes or other tissues. The staging of ovarian cancer is the most important factor in determining a treatment plan.
  • #2 Ovarian cancer | Macmillan Cancer Support
    https://www.macmillan.org.uk/cancer-information-and-support/ovarian-cancer
    Your doctor or nurse may talk to you about having a blood test for genetic testing. This is to find out if you have a change (mutation) in the BRCA genes that can cause ovarian cancer. […] The stage describes where the cancer started and other areas it may have spread to. Grading describes how the cancer cells look under the microscope compared with normal cells. […] Knowing the stage and grade helps your doctors plan the best treatment for you. […] A team of specialists will meet to discuss the best possible treatment for you. This is called a multidisciplinary team (MDT). […] Your cancer doctor and specialist nurse will explain the different treatments and their side effects. […] You usually have surgery to remove all or as much of the cancer as possible. It usually involves removing the womb, ovaries and fallopian tubes.
  • #2 Ovarian cancer treatment is making strides but early diagnosis still key
    https://health.ucdavis.edu/news/headlines/ovarian-cancer-treatment-is-making-strides-but-early-diagnosis-still-key/2023/09
    „The test is not something we feel can be solely relied on as a diagnostic tool.” […] While chemotherapy is still a standard approach to treating ovarian cancer, targeted therapy is playing a larger role in the treatment of UC Davis ovarian cancer patients. […] „Every tumor has its own genetic makeup,” Nguyen said. „When tumor cells are developing, there are different mechanisms that can turn on and off genetic mutations, so we are using the genetics of the cancer itself to guide treatment.” […] „We want our patients and their caregivers to know that we are there for them, whether it is to provide emotional, nutritional, or even financial support,” Brooks said.
  • #2 CoxHealth | Ovarian Cancer: Tests After Diagnosis
    https://www.coxhealth.com/condition/ovarian-cancer-tests-after-diagnosis/
    After an ovarian cancer diagnosis, you’ll likely need more tests. These tests help your health care providers learn more about the cancer. They can help show if it has grown into nearby tissues or spread to other parts of your body. The test results help your providers work with you to decide the best ways to treat the cancer. […] Some of the tests used after diagnosis include: […] Genetic testing and counseling should be part of the management of ovarian cancer. Everyone with ovarian cancer should be tested at the time of diagnosis or as soon as possible for certain types of gene changes (mutations). Genetic testing can be done with blood, saliva, or pieces of the tumor. Testing can help guide treatment decisions. […] Changes in the BRCA1 and BRCA2 genes can mean that certain treatments are more likely to work for epithelial ovarian cancer.
  • #2 How is Ovarian Cancer Detected? | OCRA
    https://ocrahope.org/for-patients/gynecologic-cancers/ovarian-cancer/detection-diagnosis/
    If a doctor suspects ovarian cancer, they may perform tests such as a pelvic exam, transvaginal ultrasound, CT scan, or CA-125 blood test to learn more. […] A surgical biopsy is the only way to make a definitive diagnosis of ovarian cancer. […] Ovarian cancer also cannot be diagnosed through a Pap smear, which only screens for cervical cancer. […] However, a surgical biopsy is the only definitive way to diagnose ovarian cancer. […] A surgical biopsy is the only way to definitively diagnose ovarian cancer. […] The only way to definitively determine if a patient has ovarian cancer is through a biopsy. […] CA-125 blood test, or Cancer Antigen 125 is a test that measures a protein that is elevated in more than 80% of advanced ovarian cancers and 50% of early-stage cancers. […] Although a CA-125 blood test can be a useful tool for the diagnosis of ovarian cancer, it is not uncommon for a CA-125 count to be elevated in premenopausal women due to benign conditions since it fluctuates as part of their normal menstrual cycle, or due to benign conditions unrelated to ovarian cancer, such as diverticulitis, endometriosis, liver cirrhosis, pregnancy, or uterine fibroids. […] The CA-125 test is most helpful in postmenopausal women with a pelvic mass. […] For these reasons, the National Cancer Institute and the United States Preventive Services Task Force do not endorse using it to screen women for ovarian cancer who are at ordinary risk or in the general population.
  • #2 Diagnosis – Ovarian cancer – Cancer Institute | Northwell Health
    https://cancer.northwell.edu/cancer-care/ovarian-cancer/diagnosis
    CT scans: A computer tomography (CT) scan is an X-ray procedure that records multiple overlapping images from different angles, for a detailed scan of the area. […] Intravenous pyelogram (IVP): An intravenous contrast dye is given and travels to the reproductive organs to produce X-rays or CT scans of greater clarity. These are useful for detecting tumors or blockages and can help to see how advanced the cancer is. […] Biopsy: In a biopsy, a small sample of cells is collected for examination by a pathologist, who will check for signs of cancer. This test is crucial for an accurate ovarian cancer diagnosis and is usually done with a procedure called a laparotomy. […] Laparotomy: A thin, lighted tube (a laparoscope) is inserted through a small incision in the abdomen to remove tissue for a biopsy, or small benign cysts and cancers. It can also be useful to see whether cancer has spread.
  • #2 Patient education: Ovarian cancer diagnosis and staging (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/ovarian-cancer-diagnosis-and-staging-beyond-the-basics/print
    Initial surgery — A surgical procedure called exploratory laparotomy is typically recommended when ovarian cancer is suspected. […] During the procedure, the surgeon makes an abdominal incision (usually vertically) and examines the organs within the pelvis and abdomen for signs of cancer. […] If the pathologist finds evidence of ovarian cancer on frozen section analysis, the surgeon will then attempt to remove as much of the cancerous tissue as possible. […] Based upon the findings during exploratory surgery, the tumor is formally „staged” according to the size, extent, and location of the cancer, as well as how aggressive the tumor is (also referred to as the „grade” of the tumor). […] The stage of an ovarian cancer is designated by a Roman numeral (between I and IV) and a letter (A, B, or C). […] Recommendations for treatment after surgery depend upon the disease stage. […] Treatment involves removing all visible evidence of cancer during exploratory surgery; some people are candidates for chemotherapy as well.
  • #2 Diagnosing Ovarian Cancer | Willamette Valley Cancer Institute
    https://www.oregoncancer.com/ovarian-cancer/diagnosis
    Biopsy: To remove tissue or fluid to look for cancer cells. Based on the results of the blood tests and ultrasound, your doctor may suggest surgery (a laparotomy) to remove tissue and fluid from the pelvis and abdomen. Surgery is usually needed to diagnose ovarian cancer. […] A pathologist uses a microscope to look for cancer cells in the tissue or fluid. If ovarian cancer cells are found, the pathologist describes the grade of the cells. Grades 1, 2 and 3 describe how abnormal the cancer cells look. Grade 1 cancer cells are not as likely as to grow and spread as Grade 3 cells.
  • #2 Ovarian Cancer Diagnosis | NYU Langone Health
    https://nyulangone.org/conditions/ovarian-cancer/diagnosis
    Your doctor may order blood tests to check for elevated levels of proteins that may indicate ovarian cancer is present, and what type it may be. […] If imaging tests and CA-125 tests give doctors a strong indication that ovarian cancer is present, they can perform a surgical assessment to confirm a diagnosis and often treat the cancer at the same time. […] If imaging tests suggest that you have ovarian cancer but your doctor needs more information before recommending surgery, he or she may refer you to an interventional radiologist, who can perform a needle or core biopsy.
  • #2 Tests for Ovarian Cancer | How Is Ovarian Cancer Diagnosed? | American Cancer Society
    https://www.cancer.org/cancer/types/ovarian-cancer/detection-diagnosis-staging/how-diagnosed.html
    An x-ray might be done to determine whether ovarian cancer has spread (metastasized) to the lungs. […] The only way to determine for certain if a growth is cancer is to remove a piece of it and examine it in the lab. This procedure is called a biopsy. […] If you have ascites (fluid buildup inside the abdomen), samples of the fluid can also be used to diagnose the cancer. […] Your doctor will also order a CA-125 test. Women who have a high CA-125 level are often referred to a gynecologic oncologist, but any woman with suspected ovarian cancer should see a gynecologic oncologist, as well. […] If you have been diagnosed with an epithelial ovarian cancer, your doctor will likely recommend that you get genetic counseling and genetic testing for certain inherited gene changes, even if you do not have a family history of cancer.
  • #2 Diagnosis and Stages of Ovarian Cancer – Brigham and Women’s Hospital
    https://www.brighamandwomens.org/cancer/ovarian-cancer/diagnosis-and-stages-ovarian-cancer?TRILIBIS_EMULATOR_UA=…%3Fcmp%3Dhrgn%3Fcmp%3Dhrgn%2Caqkljlpwmmk%2F1000
    The stages of epithelial ovarian cancer are: […] Stage I: The cancer is in one or both of the ovaries. Cancer cells may be growing on the surface of the ovaries, inside the ovaries or in fluid that surrounds the abdomen. […] Stage II: The cancer is in one or both ovaries and in other areas in the pelvis. Cancer cells may be in the fallopian tubes, uterus or other areas in the pelvis and in the tissue or fluid that surrounds the abdomen. […] Stage III: The cancer has spread from the ovaries to the abdomen or nearby lymph nodes. Cancer cells may also have spread to the outside of the liver. […] Stage IV: The cancer has spread to other areas of the body, such as the as the liver, the lungs or in the fluid around the lungs.
  • #2 Diagnosis & Tests for Ovarian Cancer | Nebraska Hematology Oncology – Cancer Care Treatment Blood Disorders Clinical Trials Lincoln Nebraska (NE)
    https://www.yourcancercare.com/types-of-cancer/ovarian-cancer/diagnosis-tests-for-ovarian-cancer
    Once a diagnosis of ovarian cancer has been established, the level of CA-125 in the blood is a useful indicator of cancer growth during or after treatment. […] Following surgical removal and staging of ovarian cancer, a final stage will be given. […] All treatment information concerning ovarian cancer is categorized and discussed by the stage. […] Stage I: Cancer is found only in one or both of the ovaries. […] Stage II: Cancer is found in the ovaries and has spread to the uterus (womb), the fallopian tubes, or other areas within the pelvis. […] Stage III: Cancer is found in the ovaries and has spread to other body locations within the abdomen, such as the surface of the liver, intestine or lymph nodes. […] Stage IV: Cancer is found in the ovaries and has spread outside the abdomen or inside of the liver. […] Recurrent disease means that the cancer has returned (recurred) after it has been treated. Refractory disease means the cancer is no longer responding to treatment.
  • #2 Ovarian Cancer: Symptoms, Diagnosis & Treatment
    https://my.clevelandclinic.org/health/diseases/4447-ovarian-cancer
    Providers can diagnose ovarian cancer during surgery. Typically, if they find abnormal growths, theyll remove them during the same procedure. […] Staging is important because it helps your healthcare provider design a tailored treatment plan for you. Your healthcare provider will talk with you about your treatment options. […] The goal in treating cancer is to remove as much, if not all, cancer from your body as possible. Common ovarian cancer treatments include: […] After youve completed ovarian cancer treatment, your healthcare provider will want to see you regularly for observation. You may have routine appointments to check and make sure the cancer hasnt returned over time. […] If you have a genetic mutation such as BRCA mutation, your healthcare provider may recommend risk-reducing surgery to remove your ovaries and tubes before they become cancerous.
  • #2 Ovarian cancer: Diagnosis and treatment strategies (Review)
    https://www.spandidos-publications.com/10.3892/ol.2024.14574
    Currently, the ovarian cancer molecular markers routinely detected in clinical practice are cancer antigen 125 (CA125), carcinoembryonic antigen (CEA), human epididymis protein 4 (HE4), carbohydrate antigen 19-9 (CA19-9), mesothelin, alpha-fetoprotein, PARP, folate receptor, TP53, homologous recombination deficiency, BRCA1/2, and AXL; however, the detection of only one of these markers often provides an inaccurate result. […] Nanotechnology has recently demonstrated great potential for the diagnosis of ovarian cancer due to its high accuracy and low invasiveness. However, the cost and technical requirements are high, which might limit its clinical applications. […] Histopathological examination is key in the diagnosis of ovarian cancer. The microscopic observation of tissue samples enables pathologists to accurately diagnose cancer and observe its biological characteristics.
  • #2 Researchers Leverage AI to Develop Early Diagnostic Test for Ovarian Cancer | News Center
    https://news.gatech.edu/news/2024/01/29/researchers-leverage-ai-develop-early-diagnostic-test-ovarian-cancer
    Based on their computer models, the researchers have developed what they believe will be a more clinically useful approach to ovarian cancer diagnosis whereby a patients individual metabolic profile can be used to assign a more accurate probability of the presence or absence of the disease. […] This personalized, probabilistic approach to cancer diagnostics is more clinically informative and accurate than traditional binary (yes/no) tests, McDonald says. […] Clearly, there is a tremendous need for an accurate early diagnostic test for this insidious disease, McDonald says. […] Because of this high-level molecular heterogeneity among patients, the identification of a single universal diagnostic biomarker of ovarian cancer has not been possible, McDonald says. For this reason, we opted to use a branch of artificial intelligence machine learning to develop an alternative probabilistic approach to the challenge of ovarian cancer diagnostics.
  • #2 New more accurate ovarian cancer blood test: Hudson Institute
    https://www.hudson.org.au/news/melbourne-team-on-the-verge-of-a-more-accurate-test-for-ovarian-cancer/
    There is no accurate and reliable detection test for ovarian cancer a pap test does not detect ovarian cancer. […] Ovarian cancers are often indistinguishable from common, non-cancerous disease. […] Currently patients undergo a combined CA-125 blood test and ultrasound to provide an assessment of disease. However, neither is sufficient for an accurate diagnosis and they are only used for surgical referral. […] Invasive surgery to remove the ovaries remains the only way to definitively diagnose the presence of malignant disease. […] As a result, a large proportion of women experience a cancer scare, undergo unnecessary anxiety, trauma and invasive surgery due to the lack of accurate diagnostic technology. […] The CLEO Surgical Triage Test is being developed as an easy to administer blood test that accurately distinguishes benign from malignant disease without surgical intervention.
  • #2 How is ovarian cancer diagnosed? | Cancer Australia
    https://www.canceraustralia.gov.au/cancer-types/ovarian-cancer/how-ovarian-cancer-diagnosed
    Multiple tests, including physical exams, imaging, blood tests, and surgery, may be used to diagnose ovarian cancer, with biopsy being the definitive method for confirmation, and staging helps determine treatment options. […] A number of tests may be done to investigate symptoms of ovarian cancer and confirm a diagnosis. The more common tests include: physical examination of the abdomen and pelvis, including rectal examination; imaging of the pelvis and abdomen using transvaginal ultrasound, abdominal ultrasound, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans or positron emission tomography (PET) scans; chest X-rays; blood tests to check for tumour markers such as CA-125, and to measure complete blood count and levels of chemicals in the blood; use of an endoscope to see inside the gastrointestinal tract, such as a colonoscopy; Surgery to visualise the tumour and take samples of abnormal areas (biopsy) to diagnose and/or stage the cancer; Molecular tests and genetic testing to look for any inherited mutations to guide management.
  • #2 Ovarian Cancer: Symptoms, Diagnosis & Treatment
    https://my.clevelandclinic.org/health/diseases/4447-ovarian-cancer
    Its important to pay close attention to your body and let your provider know if anything unusual is happening. Observation is key after ovarian cancer treatment. […] The overall five-year survival rate for ovarian cancer is 49%. That means that approximately 49% of people diagnosed with ovarian cancer are alive five years from diagnosis.
  • #3 Early Diagnosis of Ovarian Cancer: A Comprehensive Review of the Advances, Challenges, and Future Directions
    https://www.mdpi.com/2075-4418/15/4/406
    Ovarian cancer (OC), the seventh most common cancer in women and the most lethal gynecological malignancy, is a significant global health challenge, with >324,000 new cases and >200,000 deaths being reported annually. OC is characterized by late-stage diagnosis, a poor prognosis, and 5-year survival rates ranging from 93% (early stage) to 20% (advanced stage). […] Current diagnostic modalities, including imaging techniques (transvaginal ultrasound, computed/positron emission tomography, and magnetic resonance imaging) and biomarkers (CA-125 and human epididymis protein 4), with varying degrees of sensitivity and specificity, have limited efficacy in detecting early-stage OC. […] This review focuses on the early diagnosis of OC, comprehensively summarizing the disease’s pathophysiology and risk factors, current diagnostic approaches, screening strategies, emerging technologies, and the associated challenges.
  • #3 Diagnosis – Ovarian Cancer – Cancers We Treat – Wilmot Cancer Institute – University of Rochester Medical Center
    https://www.urmc.rochester.edu/cancer-institute/cancers/ovarian/diagnosis
    CA 125 test: This measures the blood level of CA 125, a protein thats released by cells that can be a sign of ovarian cancer. […] HE4 test: This measures the blood level of HE4, a protein thats released by ovarian cancer cells. […] Imaging tests: These include CT scans, MRIs, and PET scans, to identify malignancies. […] Laparoscopy: A doctor uses a thin, lighted tube with a small camera to inspect the ovaries and pelvic region for signs of cancer.
  • #3 Ovarian cancer: Diagnosis and treatment strategies (Review)
    https://www.spandidos-publications.com/10.3892/ol.2024.14574
    Gene expression profiling is useful in ovarian cancer, as it can provide deeper insights into the molecular mechanisms underlying this multifaceted condition. […] Next-generation sequencing (NGS) technology offers the capability to sequence vast amounts of nucleotides quickly and at a cost that is significantly lower than that of traditional methods, such as Sanger sequencing. […] Despite remarkable progress in the diagnosis, targeted therapy and immunotherapy of ovarian cancer, early detection and accurate diagnosis are the key to successful treatment. The emergence of novel biomarkers combined with artificial intelligence-based imaging technologies is expected to revolutionize diagnostic capabilities.
  • #3 Researchers Leverage AI to Develop Early Diagnostic Test for Ovarian Cancer | News Center
    https://news.gatech.edu/news/2024/01/29/researchers-leverage-ai-develop-early-diagnostic-test-ovarian-cancer
    The researchers developed their integrative approach by combining metabolomic profiles and machine learning-based classifiers to establish a diagnostic test with 93 percent accuracy when tested on 564 women from Georgia, North Carolina, Philadelphia and Western Canada. […] Further studies have been initiated to study the possibility that the test is able to detect very early-stage disease in women displaying no clinical symptoms, McDonald says.
  • #3 New more accurate ovarian cancer blood test: Hudson Institute
    https://www.hudson.org.au/news/melbourne-team-on-the-verge-of-a-more-accurate-test-for-ovarian-cancer/
    Improved early evaluation of patients using a simple blood test, that provides an actual cancer diagnostic assessment before surgery is considered; […] High specificity and sensitivity to identify cancer, allowing efficient referral of patients to an appropriate gynaecological oncology surgeon for treatment; […] Patients that are diagnosed with non-cancerous growths will benefit from more conservative management strategies; and […] Substantial reduction in stress and anxiety experienced by women who undergo a cancer scare and must wait for a surgical diagnosis. […] This new test will help ensure that an optimal management plan can be put in place early, which will streamline the referral process and provide the best care for patients. […] Pending regulatory approval, the CLEO Triage Test also has the potential to provide significant benefits to the broader community, including cost savings in the health care system (government, hospital, health insurance);